Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions

Journal of Clinical Investigation

Volumn 113, Issue 1, 2004, Pages 115-123

  Du, Jie ^a   Wang, Xiaonan ^b   Miereles, Christiane ^b   Bailey, James L ^b   Debigare, Richard ^b   Zheng, Bin ^b   Price, S Russ ^b   Mitch, William E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 3 INHIBITOR; CYTOKINE; INSULIN; MUSCLE PROTEIN; MYOSIN; MYOSIN ADENOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; RECOMBINANT ENZYME; UBIQUITIN; CASP3 PROTEIN, MOUSE; CASPASE; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CATABOLISM; CELL LINE; CHRONIC DISEASE; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; INJURY; INSULIN RESISTANCE; MOLECULAR WEIGHT; MUSCLE ATROPHY; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SEPSIS; UREMIA; ANIMAL; CELL CULTURE; METABOLISM; MOUSE; SKELETAL MUSCLE;

ACTINS; ACTOMYOSIN; ADENOSINE TRIPHOSPHATE; ANIMALS; CASPASE 3; CASPASES; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; MICE; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; MUSCLE, SKELETAL; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 85047693596     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18330     Document Type: Article

References (46)

1. Mitch, W.E., and Goldberg, A.L. 1996. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome system. N. Engl. J. Med. 335:1897-1905.
2. Lecker, S.H., Solomon, V., Mitch, W.E., and Goldberg, A.L. 1999. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129:227S-237S.
3. ++-activated and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc. Natl. Acad. Sci. USA. 93:2714-2718.
4. Tiao, G., et al. 1997. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J. Clin. Invest. 99:163-168.
5. Pickering, W.P., et al. 2002. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int. 61:1286-1292.
6. Llovera, M., et al. 1999. Ubiquitin gene expression is increased in human muscle undergoing neurogenic involvement. Neurochem. Int. 34:137-140.
7. Llovera, M., et al. 1998. Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. Int. J. Mol. Med. 2:69-73.
8. Williams, A.B., Sun, X., Fischer, J.E., and Hasselgren, P.-O. 1999. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery. 126:744-749.
9. Lecker, S.H., et al. 1999. Ubiquitin conjugation by the N-end rule pathway and mRNas for its components increase in muscles of diabetic rats. J. Clin. Invest. 104:1411-1420.
10. Solomon, V., Lecker, S.H., and Goldberg, A.L. 1998. The N-end rule path way catalyzes a major fraction of the protein degradation in skeletal muscle. J. Biol. Chem. 273:25216-25222.
11. Bailey, J.L., et al. 1996. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J. Clin. Invest. 97:1447-1453.
12. Price, S.R., et al. 1996. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription. J. Clin. Invest. 98:1703-1708.
13. Tawa, N.E., Odessey, R., and Goldberg, A.L. 1997. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100:197-203.
14. Solomon, V., and Goldberg, A.L. 1996. Importance of the ATP-ubiquitin-proteasome pathway in degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271:26690-26697.
15. Belizario, J.E., Lorite, M.J., and Tisdale, M.J. 2001. Cleavage of caspases-1, -6, -8 and -9 substrates by proteases in skeletal muscle from mice undergoing cancer cachexia. Br. J. Cancer. 84:1135-1140.
16. Vescovo, G., et al. 2000. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart. 84:431-437.
17. Richard, I., et al. 2000. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated I-kappa Balpha/nuclear factor kappa B pathway perturbation in mice. J. Cell. Biol. 151:1583-1590.
18. Dalla Libera, L., Zennaro, R., Sandri, M. Ambrosio, G.B., and Vescovo, G. 1999. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am. J. Physiol. 277:C982-C986.
19. Sandri, M. Minetti, C., Pedemonte, M., and Carraro, U. 1998. Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab. Invest. 78:1005-1016.
20. Mashima, T., et al. 1997. Actin cleavage by CPP 32/apopain during the development of apoptosis. Oncogene. 14:1007-1012.
21. Kayalar, C., Ord, T., Testa, M.P., Zhong, L.T., and Bredesen, D.E. 1996. Cleavage of actin by interleukin-1 beta-converting enzyme to reverse DNAase I inhibition. Proc. Natl. Acad. Sci. U. S. A. 93:2234-2238.
22. Hasselgren, P.-O., Warner, B.W., James, H., Takehara, H., and Fischer, J.E. 1987. Effect of insulin on amino acid uptake and protein turnover in skeletal muscle from septic rats: evidence for insulin resistance of protein degradation. Arch. Surg. 122:228-233.
23. Cecchin, F., Ittoop, O., Sinha, M.K., and Caro, J.F. 1988. Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats. Am. J. Physiol. 254:E394-E401.
24. Yu, C., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277:50230-50236.
25. Baracos, V., Langman, M., and Mak, A. 1989. An in vitro preparation of the extensor digitorum communis muscle from the chick (Gallus domesticus) for studies of protein turnover. Comp. Biochem. Physiol. A. 92:555-563.
26. Clark, A.S., and Mitch, W.E. 1983. Comparison of protein synthesis and degradation in incubated and perfused muscle. Biochem. J. 212:649-653.
27. Franch, H.A., Wang, X., Sooparb, S., Brown, N.S., and Du, J. 2002. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J. Am. Soc. Nephrol. 13:903-909.
28. Yamaguchi, H., and Wang, H.-G. 2001. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene. 20:7779-7786.
29. Nicholson, D.W., et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:37-43.
30. Thornberry, N.A., and Lazebnik, Y. 1998. Caspases: enemies within. Science. 281:1312-1316.
31. Huang, J., and Forsberg, N.E. 1998. Role of calpain in skeletal-muscle protein degradation. Proc. Natl. Acad. Sci. U. S. A. 95:12100-12105.
32. Williams, A.B., et al. 1999. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J. 13:1435-1443.
33. Deval, C., et al. 2001. Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem. J. 360:143-150.
34. Baracos, V.E., DeVivo, C., Hoyle, D.H.R., and Goldberg, A.L. 1995. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. Physiol. 268:E996-E1006.
35. Medina, R., Wing, S.S., Haas, A., and Goldberg, A.L. 1991. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed. Biochim. Acta. 50:347-356.
36. Mitch, W.E., et al. 1994. Metabolic acidosis stimulates muscle protein degradation by activating the ATP-dependent pathway involving ubiquitin and proteasomes. J. Clin. Invest. 93:2127-2133.
37. Mitch, W.E., et al. 1999. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. 276:C1132-C1138.
38. Kulik, G., Klippel, A., and Weber, M.J. 1997. Antiapoptotic signaling by the insulin-like growth factor-1 receptor, phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 17:1595-1606.
39. Tomas, F.M., et al. 1991. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGP-I. Biochem. J. 276:547-554.
40. Bertrand, F., et al. 1999. Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor associated factor 2 and manganese-superoxide dismutase. J. Biol. Chem. 274:30596-30602.
41. Yao, R., and Cooper, G.M. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:2003-2006.
42. Kennedy, S.G., et al. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701-713.
43. Tidball, J.G., and Spencer, M.J. 2002. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J. Physiol. 545:819-828.
44. Wing, S.S., and Goldberg, A.L. 1993. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264:E668-E676.
45. Song, Q., et al. 1997. Resistance of actin to cleavage during apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94:157-162.
46. Armstrong, R.C., et al. 2001. Caspase inhibitors reduce infarct size when dosed post perfusion in a rodent cardiac ischemia/reperfusion model. Circulation. 104:11-12. (Abstr.)